• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国 40 例感染 SARS-CoV-2 奥密克戎变异株患者的临床特征。

Clinical Characteristics of 40 Patients Infected With the SARS-CoV-2 Omicron Variant in Korea.

机构信息

Division of Infectious Diseases, National Medical Center, Seoul, Korea.

Department of Internal Medicine, National Medical Center, Seoul, Korea.

出版信息

J Korean Med Sci. 2022 Jan 17;37(3):e31. doi: 10.3346/jkms.2022.37.e31.

DOI:10.3346/jkms.2022.37.e31
PMID:35040299
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8763884/
Abstract

Since severe acute respiratory syndrome-coronavirus-2 variant B.1.1.529 (omicron) was first reported to the World Health Organization on November 24, 2021, the cases of the omicron variant have been detected in more than 90 countries over the last month. We investigated the clinical and epidemiological characteristics of the first 40 patients with the omicron variant who had been isolated at the National Medical Center in South Korea during December 4-17, 2021. The median age of the patients was 39.5 years. Twenty-two patients (55%) were women. Seventeen patients (42.5%) were fully vaccinated, and none were reinfected with the omicron. Eighteen (45%) had recent international travel history. Half of the patients (19, 47.5%) were asymptomatic, while the others had mild symptoms. Six patients (15%) showed lung infiltrations on chest image; however, none required supplemental oxygen. These mild clinical features are consistent with recent case reports on the omicron variant from other countries.

摘要

自 2021 年 11 月 24 日首次向世界卫生组织报告严重急性呼吸综合征冠状病毒 2 变异株 B.1.1.529(奥密克戎)以来,在过去一个月中,已在 90 多个国家发现了奥密克戎变异株的病例。我们调查了 2021 年 12 月 4 日至 17 日在韩国国家医疗中心隔离的 40 名奥密克戎变异株患者的临床和流行病学特征。患者的中位年龄为 39.5 岁。22 名患者(55%)为女性。17 名患者(42.5%)已完全接种疫苗,且无人再次感染奥密克戎。18 名患者(45%)有近期国际旅行史。一半的患者(19 名,47.5%)无症状,而其余患者症状较轻。6 名患者(15%)胸部影像显示肺部浸润;但无人需要补充氧气。这些较轻的临床特征与其他国家最近关于奥密克戎变异株的病例报告一致。

相似文献

1
Clinical Characteristics of 40 Patients Infected With the SARS-CoV-2 Omicron Variant in Korea.韩国 40 例感染 SARS-CoV-2 奥密克戎变异株患者的临床特征。
J Korean Med Sci. 2022 Jan 17;37(3):e31. doi: 10.3346/jkms.2022.37.e31.
2
Importation and Transmission of SARS-CoV-2 B.1.1.529 (Omicron) Variant of Concern in Korea, November 2021.2021 年 11 月韩国输入和传播的 SARS-CoV-2 B.1.1.529(奥密克戎)关切变异株
J Korean Med Sci. 2021 Dec 27;36(50):e346. doi: 10.3346/jkms.2021.36.e346.
3
SARS-CoV-2 B.1.1.529 (Omicron) Variant - United States, December 1-8, 2021.SARS-CoV-2 B.1.1.529(奥密克戎)变异株-美国,2021 年 12 月 1 日-8 日。
MMWR Morb Mortal Wkly Rep. 2021 Dec 17;70(50):1731-1734. doi: 10.15585/mmwr.mm7050e1.
4
Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics.奥密克戎 SARS-CoV-2 新变体:全球流行情况以及生物学和临床特征。
Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):8012-8018. doi: 10.26355/eurrev_202112_27652.
5
Investigation of a SARS-CoV-2 B.1.1.529 (Omicron) Variant Cluster - Nebraska, November-December 2021.调查 SARS-CoV-2 B.1.1.529(奥密克戎)变异株集群——内布拉斯加州,2021 年 11 月至 12 月。
MMWR Morb Mortal Wkly Rep. 2021 Dec 31;70(5152):1782-1784. doi: 10.15585/mmwr.mm705152e3.
6
Clinical Characteristics of Patients Who Contracted the SARS-CoV-2 Omicron Variant from an Outbreak in a Single Hospital.单一医院爆发的 SARS-CoV-2 奥密克戎变异株感染患者的临床特征。
Yonsei Med J. 2022 Aug;63(8):790-793. doi: 10.3349/ymj.2022.63.8.790.
7
Community Transmission of SARS-CoV-2 Omicron Variant, South Korea, 2021.2021 年韩国发生的 SARS-CoV-2 奥密克戎变异株社区传播。
Emerg Infect Dis. 2022 Apr;28(4):898-900. doi: 10.3201/eid2804.220006. Epub 2022 Feb 16.
8
Clinical Characteristics and Outcomes of Children With SARS-CoV-2 Infection During the Delta and Omicron Variant-Dominant Periods in Korea.韩国德尔塔和奥密克戎变异株流行期间儿童感染 SARS-CoV-2 的临床特征和结局。
J Korean Med Sci. 2023 Mar 6;38(9):e65. doi: 10.3346/jkms.2023.38.e65.
9
Time from Exposure to Diagnosis among Quarantined Close Contacts of SARS-CoV-2 Omicron Variant Index Case-Patients, South Korea.韩国 SARS-CoV-2 奥密克戎变异株确诊病例密切接触者隔离期间的发病时间。
Emerg Infect Dis. 2022 Apr;28(4):901-903. doi: 10.3201/eid2804.220153.
10
Estimation of Serial Interval and Reproduction Number to Quantify the Transmissibility of SARS-CoV-2 Omicron Variant in South Korea.估算 SARS-CoV-2 奥密克戎变异株在韩国的传播性:序列间隔和繁殖数的估计。
Viruses. 2022 Mar 4;14(3):533. doi: 10.3390/v14030533.

引用本文的文献

1
The association between chronic underlying diseases and the clinical characteristics in adult patients infected with Omicron BA.1.成人感染奥密克戎BA.1毒株的慢性基础疾病与临床特征之间的关联
J Virus Erad. 2025 Mar 14;11(2):100591. doi: 10.1016/j.jve.2025.100591. eCollection 2025 Jun.
2
Virological Aspects of COVID-19 in Patients with Hematological Malignancies: Duration of Viral Shedding and Genetic Analysis.血液系统恶性肿瘤患者中 COVID-19 的病毒学特征:病毒脱落持续时间及基因分析
Viruses. 2024 Dec 31;17(1):46. doi: 10.3390/v17010046.
3
Ratio of Infections to COVID-19 Cases and Hospitalizations in the United States based on SARS-CoV-2 Seroprevalence Data, September 2021-February 2022.基于2021年9月至2022年2月严重急性呼吸综合征冠状病毒2型血清流行率数据的美国感染病例与新冠病毒病例及住院病例的比率
Open Forum Infect Dis. 2025 Jan 16;12(1):ofae719. doi: 10.1093/ofid/ofae719. eCollection 2025 Jan.
4
Tracking temporal variations of fatality and symptomology correlated with COVID-19 dominant variants and vaccine effectiveness in the United States.追踪与 COVID-19 主要变异株和疫苗有效性相关的病死率和症状学的时间变化在美国。
Front Public Health. 2024 Sep 18;12:1419886. doi: 10.3389/fpubh.2024.1419886. eCollection 2024.
5
Science-based exit from stringent countermeasures against COVID-19: Mortality prediction using immune landscape between 2021 and 2022 in Japan.基于科学的新冠疫情严格防控措施解除:利用日本2021年至2022年免疫格局进行死亡率预测
Vaccine X. 2024 Aug 12;20:100547. doi: 10.1016/j.jvacx.2024.100547. eCollection 2024 Oct.
6
Evaluating the protective effectiveness and risk factors of ursodeoxycholic acid on COVID-19 among outpatients.评估门诊患者中熊去氧胆酸对新型冠状病毒肺炎的保护效果及危险因素。
Front Pharmacol. 2024 Jul 31;15:1381830. doi: 10.3389/fphar.2024.1381830. eCollection 2024.
7
Acute and long COVID-19 symptoms and associated factors in the omicron-dominant period: a nationwide survey via the online platform Wenjuanxing in China.奥密克戎主导期的急性和长期 COVID-19 症状及其相关因素:中国通过在线平台问卷星进行的全国性调查。
BMC Public Health. 2024 Aug 1;24(1):2086. doi: 10.1186/s12889-024-19510-w.
8
Use of wastewater from passenger ships to assess the movement of COVID-19 and other pathogenic viruses across maritime international boundaries.利用客船废水评估 COVID-19 和其他致病病毒在国际海域边界的传播。
Front Public Health. 2024 Jul 15;12:1377996. doi: 10.3389/fpubh.2024.1377996. eCollection 2024.
9
A Comparative Analysis of Innate Immune Responses and the Structural Characterization of Spike from SARS-CoV-2 Gamma Variants and Subvariants.新冠病毒伽马变异株及其亚变异株天然免疫反应的比较分析与刺突蛋白的结构表征
Microorganisms. 2024 Apr 2;12(4):720. doi: 10.3390/microorganisms12040720.
10
Outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 in a Rural Community Hospital during Omicron Predominance.在奥密克戎毒株占主导期间,一家农村社区医院爆发严重急性呼吸综合征冠状病毒2感染。
Microorganisms. 2024 Mar 28;12(4):686. doi: 10.3390/microorganisms12040686.

本文引用的文献

1
Importation and Transmission of SARS-CoV-2 B.1.1.529 (Omicron) Variant of Concern in Korea, November 2021.2021 年 11 月韩国输入和传播的 SARS-CoV-2 B.1.1.529(奥密克戎)关切变异株
J Korean Med Sci. 2021 Dec 27;36(50):e346. doi: 10.3346/jkms.2021.36.e346.
2
SARS-CoV-2 B.1.1.529 (Omicron) Variant - United States, December 1-8, 2021.SARS-CoV-2 B.1.1.529(奥密克戎)变异株-美国,2021 年 12 月 1 日-8 日。
MMWR Morb Mortal Wkly Rep. 2021 Dec 17;70(50):1731-1734. doi: 10.15585/mmwr.mm7050e1.
3
The omicron variant of SARS-CoV-2: Understanding the known and living with unknowns.奥密克戎变异株:了解已知与未知并存。
Clin Transl Med. 2021 Dec;11(12):e685. doi: 10.1002/ctm2.685.
4
Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic.奥密克戎新冠病毒变体:新冠疫情的新篇章。
Lancet. 2021 Dec 11;398(10317):2126-2128. doi: 10.1016/S0140-6736(21)02758-6. Epub 2021 Dec 3.
5
Covid-19: South Africa's surge in cases deepens alarm over omicron variant.新冠疫情:南非病例激增加深了对奥密克戎变种的担忧。
BMJ. 2021 Dec 3;375:n3013. doi: 10.1136/bmj.n3013.